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chromatin remodeling complexes, the molecular motorset Cellulaire
that use energy derived from ATP hydrolysis to disruptIllkirch Cedex
chromatin structure (Peterson, 2002). These complexesC.U. de Strasbourg, 67404
are attractive candidates for overcoming the energeticFrance
barriers produced by chromatin assembly, thereby pro-
moting signal controlled chromatin reorganization and
gene induction. Indeed, the first chromatin remodelingSummary
complex, the yeast Swi/Snf complex, was discovered
for its roles in mating type switching and sucrose fer-T cells develop through distinct stages directed by a
mentation in response to environmental signals (henceseries of signals. We explored the roles of SWI/SNF-
the name switch/sucrose non-fermenting) (Winston andlike BAF chromatin remodeling complexes in this pro-
Carlson, 1992). That the yeast Swi/Snf complex plays acess by progressive deletion of the ATPase subunit,
critical role in signaling inspired us to isolate the relatedBrg, through successive stages of early T cell develop-
mammalian BAF chromatin remodeling complexes andment. Brg-deficient cells were blocked at each of the
to study their roles in T cells (Chi et al., 2002; Khavaridevelopmental transitions examined. Bcl-xL overex-
et al., 1993; Wang et al., 1996a, 1996b; Zhao et al., 1998).pression suppressed cell death without relieving the
BAF complexes may be mechanistically distinct fromdevelopmental blockades, leading to the accumula-
the yeast SWI/SNF complex since they have multipletion of Brg-deleted cells that were unexpectedly cell
DNA binding domains, contain actin, and are bound tocycle arrested. These defects resulted partly from the
the insoluble matrix fraction of the nucleus (Zhao et al.,disruptions of pre-TCR and potentially Wnt signaling
1998). These observations suggest that they probablypathways controlling the expression of genes such as
have a distinct mechanism of recruitment to their sitesc-Kit and c-Myc critical for continued development.
of action. Thus, although we originally referred to themOur studies indicate that BAF complexes dynamically
as mSWI/SNF (Khavari et al. 1993), this designation mayremodel chromatin to propel sequential develop-
be misleading. BAF complexes contribute to T cell subli-mental transitions in response to external signals.
neage differentiation by reciprocally regulating CD4/8
(Chi et al., 2002). In mature T cells, TCR stimulationIntroduction
rapidly stabilizes the binding of BAF complexes to chro-
matin, highlighting the roles of BAF complexes in signal-
Development of T lymphocytes bearing  antigen re- ing (Zhao et al., 1998). In contrast to the yeast complex,
ceptors (TCR) is a multistep process that depends on which is monomorphic, several subunits of BAF com-
a series of external signals given in a specific sequence plexes are encoded by gene families that are coex-
(Figure 1A). Beginning at about day 14 of embryogene- pressed in the same cell, thus leading to their combina-
sis, lymphocyte precursors colonize the thymic anlage. torial assembly and the generation of perhaps hundreds
These cells express neither CD4 nor CD8 and hence are of complexes (Wang et al., 1996a, 1996b). The signifi-
called double-negative (DN) cells. DN cells pass through cance of the heterogeneity of BAF complexes is unclear.
four successive stages (DN1–4) that are recognizable For example, although mutations in Brg and its homolog
based on the differential expression of the IL-2 receptor Brm cause different phenotypes in mice, with the former
CD25 and the adhesion molecule CD44. IL-7R and c-Kit producing early embryonic lethality (Bultman et al.,
signaling are required for the survival and/or prolifera- 2000) and the latter little defects (Reyes et al., 1998), the
tion of DN1 and DN2 cells (Akashi et al., 1998; Di Santo lack of strong phenotypes in the Brm mutants appears to
and Rodewald, 1998; Maraskovsky et al., 1997). Cells result from the ability of Brg to compensate for Brm
at the subsequent DN3 stage undergo Rag-catalyzed (Reyes et al., 1998). Indeed, Brm and Brg are often coor-
somatic recombination at the TCR locus and express dinately downregulated in human tumors, and Brm can
a pre-TCR complex that signals the transition to the function interchangeably with Brg to suppress trans-
formed phenotypes (Reisman et al., 2002).
While homozygous germline Brg deletion is early em-*Correspondence: crabtree@cmgm.stanford.edu
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Figure 1. Cre-Mediated Deletion of a Floxed Brg Allele in Thymocytes
(A) Thymocyte development proceeds via DN→ISP→DP→SP stages as defined by CD4, CD8, CD25, and CD44 expression (Godfrey et al.,
1993). ISP and DP cells are identical to DN4 cells in being CD25CD44/low, and the three cell types are collectively termed post-DN3 cells
(Chi et al., 2002). DN2, DN4, ISP cells are proliferating blasts, as denoted by their large sizes. Also indicated is the extent of the deletion of
the floxed Brg gene as described in the text.
(B–D) Brg deletion was partial in DN3 but complete in DN4 cells in BrgF/Cre/ mice. Thymocytes from a BrgF/Cre/ mouse were stained
with CD4, CD8, and TCR to determine the CD4/8 expression pattern of total thymocytes (left panel). To determine the composition of DN
cells, thymocytes were stained with CD4, CD8, CD3, CD25, and CD44, and the CD4CD8CD3 cells were resolved into four subsets based
on CD25/44 expression (right panel). DN3 and DN4 cells were sorted and the efficiencies of deletion of the floxed Brg allele determined by
PCR (Figure 1C) using primers (Sumi-Ichinose et al., 1997) that detected the floxed or rearranged allele, the latter becoming detectable as a
result of Cre-mediated excision of two exons encoding part of the ATPase domain (Figure 1D). The current study also used a constitutive
(germline) knockout allele (Bultman et al., 2000) lacking two upstream exons and encoding a truncated protein missing the entire C terminus
of Brg (Figure 1D).
bryonic lethal (Bultman et al., 2000), heterozygous Brg 2002). Using the PCR primers flanking the 3 loxP site
and thus detecting both WT and the floxed alleles (Figuredeletion impairs CD8 activation, suggesting a limiting
1D), we found that the floxed allele was virtually com-and specific role of Brg in T cell development (Chi et
pletely deleted in total thymocytes (Figure 1C, top panel,al., 2002). To further examine the function of Brg, we
lane 2) and in DN4 cells (lane 4), as judged by the loss ofdeleted Brg specifically in thymocytes. Fortuitously, Brg
the amplicon representing the floxed allele. In contrast,was deleted gradually through several stages of signal-
deletion was undetectable in DN3 cells by this assaydirected early T cell development, which revealed the
(lane3). However, a more sensitive PCR assay that de-essential roles of Brg at all these stages.
tects the rearrangement of the loxP sites (Figure 1D)
indicates the floxed Brg was partially deleted in DN3
Results (Figure 1C, bottom panel lane 3) and DN2 cells (not
shown). The inefficient deletion at DN3 is unexpected,
A Lck-Cre Transgene Produces Progressive Deletion as the same LCK-Cre transgene completely excised a
of a Lox P-Flanked Brg Gene during Early floxed Notch-1 allele by the DN3 stage (Wolfer et al.,
Thymic Development 2002). It is possible that the loxP sites in the floxed Brg
We used Cre-mediated excision to delete Brg specifi- mice are not readily accessible or rearranged. Neither
cally in T cells. Cre was expressed under the control of DN2, DN3, nor DN4 cells showed any defect in CD4
the Lck proximal promoter, which is active in immature silencing in these mice (not shown), as predicted from
T cells (Lee et al., 2001). Two exons essential for ATPase the fact that one copy of Brg is sufficient to silence CD4
activity of the Brg gene were floxed as previously de- (Chi et al., 2002), and demonstrated that the deleted
scribed (Sumi-Ichinose et al., 1997). We first determined gene does not produce a dominant-negative protein.
the efficiency of deletion in BrgF/;Cre/ mice bearing
one floxed and one wild-type Brg allele. These mice Homozygous Brg Deletion Derepresses CD4
displayed normal numbers of total thymocytes and DN in a Fraction of DN Cells and Blocks
subsets (Figure 1B), supporting our previous findings the DN4→DP Transition
that heterozygous germline Brg deletion does not We analyzed the effect of homozygous Brg deletion in
BrgF/; Cre mice bearing the floxed Brg allele togethergrossly perturb thymocyte development (Chi et al.,
Brg in T Cell Development
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with the germline deleted allele of Brg. We found that subset of DN cells, significantly depleted DN4 cells, and
completely blocked the DN4→DP transition.the thymi of the Brg F/;Cre/ mice were as small as
those seen in Rag/ mice, with 40- to 100-fold reduction
in cell numbers. DP and SP cells were completely ab- Brm Expression Is Independent of Brg
sent, as revealed by the CD4/8 expression profile of In addition to Brg, mammalian cells also express the Brg
the total thymocytes (Figure 2A, column 1, row B). The homolog Brm. As Brm and Brg are often coordinately
remaining thymocytes contained a few CD4 cells, con- downregulated in human tumors (Reisman et al., 2002),
sistent with the role of Brg in CD4 silencing. The the striking defects in thymocyte development resulting
CD4CD8cells contained normal numbers of DN1-DN3 from Brg deletion prompted us to examine whether Brm
cells, as expected from the fact that Brg was minimally expression was abolished in Brg-deficient cells. Semi-
deleted from these cells. In contrast, the numbers of the quantitative RT-PCR using Brg-deficient DN4 cells indi-
DN4 cells were reduced about 6-fold (column 2, row B; cated that Brm transcription was independent of Brg in
Figure 2B), and the remaining DN4 cells were completely T cells (Figure 2D). Thus Brm was unable to compensate
arrested in development, based on the complete ab- for the loss of Brg during thymic development. Consis-
sence of DP cells described before (column 1, row B). tent with these data, Brm is dispensable for thymic
A caveat is that the CD4CD8 cells in the DN4 compart- development (M. Yaniv and M. Malissen, personal com-
ment may not be T cells, but rather contaminants from munication), indicating that the functions of Brg- and
other lineages. Thus, the apparent lack of DP cells could Brm-containing BAF complexes are distinct during T cell
have resulted from the complete depletion of DN4 cells, development.
as opposed to the block in the differentiation of the
remaining DN4 cells. We ruled out this possibility by Brg Deletion Blocks the Differentiation of Most,
showing that the DN cells in the DN4 compartment were if Not All, DN Subsets
predominantly Thy1.2 (see Supplemental Figure S1 at The primary cause of the block in the DN4→DP transition
http://www.immunity.com/cgi/content/full/19/2/169/ might be the death of DN4 cells, the failure of the DN4
DC1). cells to differentiate, or both. To distinguish between
To pinpoint which subsets of DN cells derepressed these possibilities, we introduced a Bcl-xL transgene,
CD4, we first used CD25/44 to resolve immature (CD3/lo) under the control of the LCK proximal promoter, into
thymocytes into DN1, DN2, DN3, and post-DN3 cells BrgF/;Cre/ mice. Bcl-xL alone did not grossly alter
(Figure 1A; Figure 2A, column 3). We then determined thymocyte development except that it increased the
the CD4/8 expression profile for these subsets (columns abundance of CD8SP cells as reported previously (Fig-
4–6; Figure 2B). The results revealed marginal CD4 dere- ure 2A, column 1, row C) (Chao and Korsmeyer 1997),
pression at both DN2 and DN3 stages, and suggested and moderately decreased the cellularity of DN cells
that the CD4 cells may represent those lacking Brg, (Figure 2B). In contrast, the Bcl-xL transgene led to a
given that Brg is required for CD4 silencing (Chi et al., dramatic, dose-dependent increase in the cell numbers
2002). The post-DN3 cells in the mutant were predomi- in Brg-deficient mice (up to 10-fold, from 3 million in
nantly comprised of CD4CD8DN4 cells, but also con- BrgF/;Cre to 8 million in BrgF/;Cre;Bclx/ to 28 million
tained a small number of CD4CD8 cells that were in BrgF/;Cre;Bclx/ mice, Figure 2A, column 1, com-
presumably DN4 cells prematurely expressing CD4 (col- pare rows A, D, E), indicating that Brg deletion indeed
umn 6, row B). caused cell death, and that the form of death could be
We then analyzed Brg deletion in various subsets of suppressed by Bcl-xL overexpression. This increase in
cells sorted from BrgF/;Cre/ mice (Figure 2C, top cellularity, as compared with that in BrgF/;Cre mice,
panel). Although there was no significant deletion of the was largely due to an increase in post-DN3 cells (column
floxed Brg allele in CD4DN3 cells, Brg was completely 3, compare row B with D), with an averaged 50-fold in-
deleted in the CD4 counterpart (lane 3), indicating that crease in CD4 DN4 cells (from 0.15 million to 7 million),
Brg deletion indeed led to CD4 derepression. Brg was and a far more dramatic increase in CD4CD8cells (from
also completely deleted in DN4 cells including CD4DN4 barely detectable to 8.5 million, column 6, compare row
cells, as expected. Most of the DN4 cells, however, B with D; see Figure 2B for the quantification of cell
retained the ability to silence CD4, because the CD4 numbers relative to WT DN subsets). However, the post-
cells only constituted a small fraction of total DN4 cells DN3 cells contained few DP cells, indicating that Bcl-
(Figure 2A, column 6, row B). It is not clear why Brg xL could not relieve the block in the DN4→DP transition.
deletion did not uniformly affect the DN4 cells as do Thus Brg is specifically required for the differentiation
mutations in BAF57, Runx1, or the CD4 silencer (Chi et of DN4 cells into DP cells. This is further supported by
al., 2002; Taniuchi et al., 2002a, 2002b; Zou et al., 2001). the fact that the Bcl-xL rescued CD4DN4 cells were
Perhaps these CD4DN4 cells represented those in about 14-fold more abundant than those in Bcl-xL con-
which Brg was only recently deleted and that residual trol mice (Figure 2A, column 2, compare row C with row
levels of Brg protein were still present, which sufficed D; Figure 2B). Both the CD4 and the CD4 DN4 cells
to repress CD4. In any case, the presence of Brg deleted were completely cell cycle arrested (see next section),
DN4 cells lacking CD4 expression suggested that the and thus their accumulation must have resulted from
CD4DN3 population also harbored cells lacking the a blockade in their exiting the DN4 compartment and
floxed Brg allele. This is indeed the case, as demon- differentiating into the DP compartment.
strated by the more sensitive PCR assay detecting the Bcl-xL overexpression also caused a preferential ac-
rearranged floxed Brg allele (data not shown). cumulation of CD4DN2 and CD4DN3 cells (Figure 2A,
columns 4 and 5, row B versus D; Figure 2B). This dem-We conclude that Brg deletion derepressed CD4 in a
Immunity
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onstrates that as in the case of DN4, Brg deletion also CD4DN2-3 cells in BrgF/;Cre mice incorporated BrdU
with efficiency comparable to the wild-type cells; aboutderepressed CD4, blocked differentiation, and caused
30% and 15% of DN2 and DN3 cells were BrdU, respec-death at the DN2-3 stages; once the cell death was
tively, in both wild-type and mutant mice (Figure 3A,suppressed by Bcl-xL, these CD4cells accumulated
rows 1 and 2), while their CD4 counterparts and DN4due to the failure in differentiation. Indeed, even the Brg-
cells showed marginal, if any, alterations in proliferationdeleted CD4DN3 cells in the BrgF/;Cre/;Bclx/ mice
(Figure 3A, row 3). Remarkably, each of the Bcl-xL res-were enriched relative to the CD4DN3 cells with the
cued CD4 DN subsets was cell cycle arrested (Figureintact floxed allele, based on the following facts. First,
3A, rows 7 and 9). This arrest is not an artifact resultingPCR assay revealed a significant enrichment of cells
from Bcl-xL overexpression for two reasons. First, al-lacking the floxed Brg allele in CD4DN3 pool from
though Bcl-xL/ transgenes moderately impaired theBrgF/;Cre/;Bcl-xL/ mice (compare upper and lower
proliferation of DN4 cells, the transgenes had little effectpanels in Figure 2C, lane 2). Second, this pool contained
on DN2 and DN3 proliferation (Figure 3A, row 5), ina substantial amount of truncated transcript derived
agreement with the report that a Bcl-2 transgene selec-from the rearranged Brg allele (Figure 2E, upper panel),
tively impairs proliferation of DN4 while sparing otherconcomitant with a substantial reduction in Brg protein
DN subsets (O’Reilly et al., 1997). Second, the Bcl-xL/level (Figure 2E, lower panel); the truncated transcript
transgene had little effect even on DN4 cells, let alonewas barely detectable in the CD4DN3 cells from the
on DN2 and DN3 cells (row 4), and yet Bcl-xL/ rescuedBrgF/;Cre mice (data not shown). These data indicate
Brg-deficient CD4 cells were cell cycle arrested. Thesethat the CD4DN3 cells lacking Brg were also impaired
data together suggest that Brg deletion tended to blockin survival and differentiation, even though they still re-
the proliferation of T cells, but it also led to rapid apopto-tained the ability to silence CD4. Interestingly, although
sis of Brg-deleted cells, and thus a proliferation defectthe Bcl-xL/ transgenes were much more effective than
could emerge only after the suppression of cell death.Bcl-xL/ in causing the accumulation to Brg-deficient
Interestingly, the CD4 DN3 and CD4DN4 cells wereDN4 cells, no difference was seen in the extents of accu-
also severely affected, consistent with the fact that thesemulation of DN2 and DN3 cells in Bcl-xL/ versus Bcl-
cells largely comprised Brg-deficient cells as did their
xL/ rescued Brg-deficient cells (Figure 2B). This sug-
CD4 counterparts (Figures 2C–2E), despite the fact that
gests that the “niches” for DN2 and DN3 cells are much
they retained the ability to silence CD4.
smaller than that for DN4 cells, and that the moderate To exclude the possibility that BrdU incorporation did
increase in the DN2 and DN3 cellularity resulting from not reflect cell proliferation, we sorted out the DN4 cells
Bcl-xL/ rescue sufficed to fill the niches, preventing from the BrdU-labeled mice and determined their DNA
further accumulation of the DN2 and DN3 cells in Bcl- contents (Figure 3C). The data demonstrate that Bcl-
xL/; BrgF/; Cre mice. xL rescued Brg-deficient cells were arrested at the G1
The effects of Bcl-xL on DN1 cells lacking Brg, how- phase of cell cycle. Finally, we found that the intracellular
ever, were inconclusive (not shown), apparently be- PCNA levels of Brg-deleted cells were reduced, with the
cause the Lck-Cre-mediated deletion is essentially un- mean fluorescence intensity (MFI) precisely paralleling
detectable in DN1 cells (Wolfer et al., 2002). the efficiency of BrdU incorporation (compare Figure 3D
Together with the fact that the Bcl-xL rescued, Brg- with 3A).
deficient DN2, DN3, and DN4 cells were all blocked in We conclude that the Bcl-xL rescued cells were ar-
proliferation (see below), the accumulation of these cells rested at the G1 phase of cell cycle, and that the accu-
in the thymus demonstrates that Brg deletion blocked mulation of these cells resulted therefore from retarded
the differentiation of most if not all subsets of DN cells. differentiation as opposed to excessive proliferation
(see Supplemental Figure S2 at http://www.immunity.
Cell Cycle Arrest of the Bcl-xL Rescued, com/cgi/content/full/19/2/169/DC1). We next sought to
Brg-Deficient Cells determine the molecular mechanisms underlying the de-
To analyze the proliferation of Brg-deficient thymocytes, velopmental defects of Brg-deficient cells.
BrdU was injected i.p. and mice sacrificed 15 min later
before BrdU incorporation was measured (Figure 3A; Defect in c-Kit Expression
see Figure 3B for the quantification of BrdU incorpora- The survival and/or proliferation of early T cells are de-
pendent on IL-7R and c-Kit signaling. Surface c-Kit ex-tion of each DN subset relative to the WT). As expected,
Figure 2. Defects in the Survival and Differentiation of Brg-Deficient Thymocytes
(A) Developmental blocks in Brg-deficient cells that could not be relieved by overexpressing Bcl-xL. Thymocytes were stained and CD4/8
and CD25/44 expressions determined for total and DN cells as described in Figure 1B (columns 1 and 2). To analyze CD4 derepression, the
immature, CD3lo/ T cells containing DN, ISP, and DP cells were first resolved into various subsets based on CD25/44 expression (column 3)
before their CD4/8 expression determined (columns 4–6).
(B) Histograms comparing the abundance of DN subsets relative to those in the WT mice that are set as 100. The CD4 DN cells in Brg
mutants (red bars) are placed on top of the CD4 counterparts for clarity. The data are averaged from three mice for each genotype.
(C) Analysis of Cre-mediated deletion by PCR.
(D) RT-PCR measuring Brg and Brm transcripts in CD4 (4) and CD4 (4) DN4 cells from BrgF/;Cre/;Bcl-xL/ mice (Mut). DN4 cells from
Bcl-xL/ mice (Ctrl) were used as a control. The Western blot (bottom panel) demonstrated the loss of Brg protein in both CD4 and CD4
DN4 cells in the mutant.




Figure 3. Cell Cycle Arrest of Brg-Deficient Cells
(A) Histograms comparing BrdU incorporation of various DN subsets. The genotypes of the mice are indicated at the right.
(B) Quantification of BrdU incorporation efficiency of various DN subsets relative to the efficiency in the WT mice. The data were averaged
from three mice.
(C) DN4 cells from Figure 3A were sorted and stained with 7AAD to determine their cell cycle status in conjunction of BrdU staining. The
sorted cells were 95% pure (data not shown).
(D) PCNA expression of various DN subsets. Cells were stained and analyzed as in (A) except that PCNA antibody was used instead of anti-BrdU.
pression was almost completely lost on the Brg-defi- reduction in c-Kit expression, as measured by RT-PCR
(Figure 4B); c-Kit was barely detectable on these cellscient, Bcl-xL rescued DN2 cells (Figure 4A). Bcl-xL
rescued DN3 and DN4 cells similarly showed significant by FACS (not shown). The defect is specific, because
Brg in T Cell Development
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Figure 4. Specific Roles of Brg in c-Kit, Myc, and NPM Expression
(A and B) c-Kit expression in DN2 as measured by FACS analysis and in DN3 or DN4 cells measured by real-time RT-PCR. For FACS analysis,
thymocytes from a c-KitW/Wv mouse and a WT littermate (c-Kit control) were used as negative and positive controls, respectively. For RT-
PCR, the mRNA level in DN3 cells from Bcl-xL/ (Ctrl) mice was set as 100.
(C) FACS analysis of IL-7R expression.
(D) Preferential depletion of DN2 cells in c-Kitw/wv mice.
(E) Real-time RT-PCR assays measuring gene expression in DN4 cells. The mRNA levels of the control mice were set as 100. The right panel,
measuring Myc and NPM expression using RNA from mice different from those used in the left panel, highlights the reproducibility and
specificity of Myc and NPM repression resulting from Brg deletion. A representative real-time PCR analysis was presented in Supplemental
Figure S3 at http://www.immunity.com/cgi/content/full/19/2/169/DC1.
(F) Real-time PCR quantifying the binding of Brg to the proximal TCF site at the Myc promoter. A region 12.2 kb downstream of the Myc
translation start codon was used as a reference for nonspecific binding (top panel). We first determined the abundance of the TCF site relative
to the reference in the J1 and in preimmune serum precipitated materials. We then divided the TCF abundance in the J1 precipitated materials
by that in the preimmune control to calculate the “fold enrichment” (bottom panel). A representative experiment was shown in Supplemental
Figure S4.
(G) FACS analysis of Bcl-2 expression.
signaling molecules such as IL-7R (Figure 4C), Jak3, or cyte number and 1.6-fold decrease in the percentage
of DN cells, resulting in a net 4-fold drop in the number ofStat6 (Figure 4E) were unaffected by Brg deletion. To
directly compare the phenotypes of Brg mutants with DN cells (Figure 4D). DN2 cells were virtually completely
depleted, but there were substantial numbers of DN3that of c-Kit-deficient adult mice, we examined the DN
subsets in 4- week-old c-Kit-deficient mice bearing a and DN4 cells. These DN3 and DN4 cells were presum-
ably produced by the few remaining DN2 cells that hadnull allele KitW together with a hypomorphic allele KitWv
that allows the mice to survive to adulthood. In the KitW/ escaped c-Kit mutation. Indeed, the remaining DN2 cells
did not have any defects in survival or proliferation (notKitWv mice, there was a 2.6-fold reduction in total thymo-
Immunity
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shown), consistent with their being escapees. These to c-Kit, Myc, and NPM repression, P21CIP1/WAF induction,
and cell cycle arrest.data suggest that the effect of c-Kit mutation was re-
stricted mainly to DN2 cells, which enabled the DN2
escapees to proliferate, differentiate, and repopulate the Brg Appears to Directly Regulate Myc
DN3 and DN4 compartments via homeostatic compen- A prediction from the hypothesis that Wnt signaling
satory mechanisms. The loss of c-Kit expression thus might use Brg to activate Myc is that Brg binds the Myc
contributed to the death/cell cycle arrest of Brg-defi- promoter, a direct target of Wnt signaling (He et al.,
cient DN2 cells, but could not account for the defects 1998). There are two perfect TCF binding sites in the
in DN3 or DN4 cells in these mutants. In fact, the defects promoter region located within 4 kb upstream of the
in c-Kit expression and DN2 expansion appeared to be translation start codon of the mouse Myc gene (Figure
secondary to the disruption in Wnt signaling essential 4F, top panel). We performed chromatin immunoprecipi-
for T cell development at multiple stages (Figure 1A), as tation assay on total thymocytes from WT mice. The
demonstrated below. J1 anti-Brg antibody, but not the preimmune serum,
selectively enriched the proximal TCF site relative to a
reference sequence downstream of the Myc gene inPotential Disruption of the Wnt Signaling Pathway
thymocytes (Figure 4F). Similar results were obtainedin Brg-Deficient Cells
with thymocytes from TCR null mice lacking SP cells,c-Kit is regulated by Wnt signaling in human colon can-
indicating the Brg bound the Myc promoter in immaturecer cells in a Brg-dependent manner (Barker et al., 2001).
T cells. The binding is specific because Brg did not bindSpecifically, Brg directly binds -catenin and a domi-
the Myc promoter in peripheral, resting T cells (Figurenant-negative mutant of Brg impairs the expression of
4F). These results suggest that Brg directly activatesthe TCF dependent gene c-Kit, in addition to three other
Myc expression in response to Wnt signaling, leadingTCF targets c-Myc, c-Myb, and ETS2. Furthermore, Brg
to cell proliferation.also genetically interacts with TCF in Drosophila. To
determine if the loss of c-Kit expression in Brg-deficient
Loss of Bcl-2 Expression in Brg-Deleted Cellscells might result from a defect in Wnt signaling, we
In addition to the well-established role of Wnt signalingexamined additional Wnt target genes. Myc was indeed
in cell proliferation, Wnt may also promote cell survival,severely repressed in the Brg deleted cells, concomitant
because TCF-1 mutation reduces the Bcl-xL proteinwith an elevation in the mRNA level of CDK inhibitor
level and impairs the viability of DP cells (Ioannidis etP21CIP1/WAF1, a direct target of Myc (van de Wetering et
al., 2001). In DN cells, Bcl-2 is the major antiapoptotical., 2002) (Figure 4E, left panel). In addition to Myc,
protein, and its expression was indeed severely reducedNucleophosmin (NPM), a Wnt-activated gene in human
in Brg-deficient cells (Figure 4G). However, it remainsembryonic cancer cells (Willert et al., 2002), was also
to be determined if the loss of Bcl-2 expression wasrepressed by Brg deletion (Figure 4E). These alterations
caused by the disruption of the Wnt pathway.were not nonspecific consequences of cell cycle arrest
seen in the Brg- deficient, Bcl-xL rescued DN4 cells for
two reasons. First, Myb and ETS2, the two Wnt-activated Disruption of the Pre-TCR Signaling Pathway
in Brg-Deficient DN3 Cellsgenes in colon cancers and often coexpressed in prolif-
erating cells, were not repressed in Brg-deficient T cells. The block in DN3→DN4 development in Brg-deficient
cells is characteristic of defects in pre-TCR signaling,Second, the Bcl-xL/ transgene, though moderately
impairing proliferation of DN4 cells, could not affect Myc as deletions of a variety of components of the pre-TCR
signaling pathway also block this transition (Fischer andor NPM expression in the DN4 cells (Figure 4E, right
panel). Malissen, 1998). An early consequence of pre-TCR sig-
naling is the enlargement and proliferation of DN3 cells.Paradoxically, expression of CD44, another Wnt-acti-
vated gene in colon cells (Wielenga et al., 1999), was DN3 blasts, marked by large cell sizes, were depleted
in Bcl-xL rescued, Brg-deficient DN3 cells (Figure 5A),moderately increased in Brg-deficient post-DN3 cells
(Figure 2A, column 3, compare row C with row D). How- suggesting that Brg deletion blocked pre-TCR directed
proliferation of DN3 cells. In contrast, the fact that Bcl-ever, CD44 expression is also increased in TCF-1-defi-
cient DN1 and DN4 cells in aged mice (Schilham et al., xL effectively suppressed the death of Brg-deficient
DN3 cells indicates that pre-TCR signaling retained the1998, Figure 2). Taken together, these data suggest that
Brg mutation blocked Wnt signaling in T cells, leading ability to promote the survival of DN3 cells. This is be-
Figure 5. Defects in Pre-TCR Signaling
(A) Lack of DN3 blasts in Bcl-xL rescued, Brg-deficient DN3 cells.
(B) RT-PCR measuring mRNA levels of mature TCR genes in DN3 and CD4DN4 cells (left panel), and PCR assessing VDJ recombination
in DN3 cells (right panel). The mutant mice used in both cases were BrgF/;Cre; Bcl-xL/. The PCR products were separated on agarose gels
and visualized by ethidium bromide staining, except for the V8 to J2 recombination that was detected by Southern blot for more accurate
quantitation of the bands (bottom figure in the right panel).
(C) Adult mice were injected i.p. with 300 l anti-CD3 supernatant. 4 days after injection, thymocytes were stained with CD4, CD8, and CD25
antibodies before FACS analysis. The cell numbers (in million) were averaged from three independent experiments.
(D) DN cells were stimulated in vitro for 3 hr with various drugs as indicated before the cells were stained with CD25 and CD69 to analyze




Figure 6. A Model for the Sequential Func-
tions of BAF Complexes in Thymocyte Devel-
opment
T cell development proceeds through suc-
cessive stages directed by external signals
such as Wnt, pre-TCR, and TCR. These and
perhaps other unidentified signals use BAF
complexes to remodel chromatin to activate
target genes and progressively shape chro-
matin structure. This drives the survival, pro-
liferation, and developmental transitions of
the developing cells, leading ultimately to the
formation of chromatin pattern characteristic
of the mature T cells. External signals may
regulate BAF complexes indirectly via other
transcription factors such as -catenin, or di-
rectly via inositol derivatives. The role of Brg
in DP→SP development is inferred from the
fact that mutations in BAF complexes prefer-
entially deplete SP cells (Chi et al., 2002), and
that BAF complexes act downstream of TCR
signaling (Zhao et al., 1998). The changing
colors of the nuclei denote the distinct chro-
matin patterns of differentiating cells.
cause antiapoptotic proteins in the Bcl-2 family cannot produced by premature CD4 expression on DN3 cells
(Chi et al. 2002, Figure 3b). 70% of the CD4CD8 cellseffectively oppose the death resulting from defects in
pre-TCR signaling (Strasser et al., 2000). That Brg was in the Rag2/;BAF57N/;Brg/ mice treated with an
anti-CD3 antibody, however, were CD25, indicatingdispensable for pre-TCR stimulated cell survival pre-
dicts that Brg deletion did not affect TCR recombina- that they were still at the DN3 stage (not shown). Thus
the major effect of anti-CD3 stimulation on DN3 cellstion or expression, as the lack of TCR expression would
have eliminated the entire spectrum of pre-TCR-depen- was to exacerbate premature CD4 derepression without
propelling the developmental transition of the DN3 cells.dent processes. Indeed, neither VDJ recombination nor
the expression of the recombined TCR genes was im- These data confirmed that BAF mutations block pre-
TCR directed events downstream of CD3.paired in Bcl-xL rescued, Brg-deficient cells (Figure 5B).
Furthermore, intracellular CD3 levels were not reduced Interestingly, the BAF57N/;Brg/ mice are still
able to produce DP cells, though the numbers of DP(not shown), suggesting that Brg deletion impaired pre-
TCR signaling downstream of CD3. cells are reduced 3-fold (Chi et al., 2002). It is not clear
why the effect of BAF mutations is more pronouncedTo verify the roles of Brg in pre-TCR signaling, we
took advantage of the fact that injection of an anti-CD3 when the DN→DP transition was promoted with the anti-
CD3 antibody as opposed to physiological pre-TCR.antibody into Rag-deficient mice, in which thymocyte
development is arrested at the DN3 stage, mimics pre- Perhaps antibody crosslinking of CD3 only produced
a suboptimal signal, which synergized with the partialTCR signaling and drives the synchronized develop-
ment of DN cells into DP cells. We thus crossed defect in the pre-TCR signaling pathway due to impaired
BAF function to completely block DN→DP development.BAF57N/;Brg/ mice (Chi et al., 2002) onto a Rag2
null background and determined if the BAF mutations The signals emanating from CD3 are transmitted
through the Calcium/Calcineurin and Ras/Map kinaseimpaired the anti-CD3- induced development. We used
the BAF57N/;Brg/ mice because the T cells in pathways, which can be activated by the pharmacologi-
cal agents ionomycin and PMA, respectively. Ionomycinthese mice had normal viability (not shown) and were
thus free from the complications of the homozygous and PMA rapidly and additively induced the expression
of CD69 and Myc in Rag2-deficient DN cells in vitroBrg null cells. We found that in the Rag2/ control mice,
antibody injection led to a 20-fold increase in thymocyte (Figure 5D). BAF mutations impaired CD69 but not Myc
induction by ionomycin or PMA, indicating that bothcellularity as a result of DP cell production (Figure 5C).
In contrast, in the BAF mutant, anti-CD3 injection failed the calcium and Ras pathways use BAF complexes to
regulate a subset of target genes. This conclusion sup-to increase total cell numbers or produce DP cells, but
rather led to a relative increase in the CD4CD8 cells ports the notion that homozygous Brg deletion only
blocked a subset of pre-TCR-dependent events as de-that constituted 53% of total thymocytes. The CD4CD8
cells normally comprise only 14% in these mice and are scribed above.
Brg in T Cell Development
179
Discussion blocks c-Kit expression. Interestingly, Brg is essential
for Wnt-regulated Myb and ETS2 expression in human
Brg Is Essential for Signal-Directed colon cells, but not in T cells. In addition, we showed
T Cell Development that Wnt/Brg activates CD44 in colon but not in T cells.
T cell development strictly depends on the external sig- These data thus highlight the tissue specificity of the
nals received from thymic stromal cells. Brg deletion Wnt/Brg signaling pathway. On the other hand, the con-
completely blocked the development of each of the DN served role of Brg in Myc induction in both colon and
subsets examined due, in part, to the disruptions of pre- thymus helps solve the puzzle that while Brg is essential
TCR and perhaps Wnt signaling pathways. Furthermore, for Rb to suppress cell cycle (Dunaief et al., 1994; Zhang
we previously found that SP cells are preferentially de- et al., 2000), Brg mutations only produce tumors in very
pleted in BAF57N/; Brg/ mice, suggesting a role of restricted tissues (Bultman et al., 2000; Reisman et al.,
Brg in DP→SP development (Chi et al., 2002). Thus, Brg 2002). As Wnt signaling is functional in many cell types,
is generally required for signal-directed T cell develop- deletion of Brg might block their proliferation via Myc
ment (Figure 6). This observation suggests a conserved repression, which should override the hyperproliferative
role of Swi/Snf-like chromatin remodeling complexes, tendency resulting from Rb inactivation. Together with
since the yeast Swi/Snf complex is required for mating the finding that Brg directly binds the TCF site in the
pheromones and nutrient sources (Winston and Carlson, Myc promoter, our data support the previous observa-
1992). Unlike the yeast complex, however, BAF com-
tions that Brg interacts with -catenin and regulates
plexes contain actin, have multiple DNA-binding sub-
Wnt target genes in colon cancers (Barker et al., 2001).
units and are associated with the nuclear matrix (Zhao
However, a conclusive demonstration of Brg actinget al., 1998), which suggests important differences be-
downstream of Wnt in T cells needs additional evidencetween these complexes.
such as genetic interactions between Brg and TCF.One may argue that BAF complexes are nonspecific
BAF mutations also impaired pre-TCR signaling, asgene activators or components of the general transcrip-
revealed by the failure of DN3 cells to express CD69 ortion machinery, and the developmental defects in Brg-
develop into DP cells upon pre-TCR signaling in BAFdeficient cells are simply a consequence of global gene
mutants. The defect in pre-TCR signaling may accountrepression. However, Brg is entirely dispensable for se-
for the cell cycle arrest of Brg-deficient DN3 cells. How-rum-induced, Ras/Mapk pathway-mediated survival
ever, BAF complexes were not essential for pre-TCRand proliferation of murine embryo fibroblasts (Bultman
induced Myc expression, and Myc mRNA levels in Brg-et al., 2000) and both Brg and Brm are dispensible for
deficient DN3 cells did not appear to be decreased (dataserum-dependent proliferation of SW13 cells (Dunaief
not shown). Thus pre-TCR might use BAF complexeset al. 1994). The ability of Bcl-xL to rescue Brg-deficient
to regulate other molecules to effect proliferation. TheT cells also argues against nonspecific deterioration of
death of Brg-deficient DN3 cells was not due a defecttranscription in these cells. Indeed, Brg deletion did not
in pre-TCR signaling, as Bcl-xL effectively suppressedimpair the expression of CD25, IL-7R, Brm, Jak3, Stat6,
the death. Neither is it likely to be caused by the defectETS2, Myb, or TCR, and instead increased the expres-
sion of CD4, CD44, and P21CIP1/WAF1. Microarray analysis in Wnt signaling, because TCF mutations do not signifi-
further demonstrates that Brg deletion altered the ex- cantly deplete DN3 cells. These data point to additional
pression of less than 5% of genes, many of which seem signaling pathways controlling the survival of DN3 cells.
to reflect the cell cycle and growth defects secondary That Brg was dispensable for pre-TCR to promote cell
to the disruption of the Wnt pathway (not shown). This survival or induce Myc demonstrates the specificity of
suggests that direct targets of Brg are very limited. In- Brg function.
deed, transient transfection of Brg into a Brg-deficient
tumor cell line acutely affects the expression of only 82
genes (Liu et al., 2001). These data indicate that Brg Role of Brg in Myc Induction via DNA Melting
mutations blocked specific signaling pathways essential An unusual feature in human Myc induction is that it
for T cell development. requires single stranded DNA binding proteins such as
External signals function to promote cell survival, pro- FBP, which binds the far upstream sequence (FUSE)
liferation, and differentiation during T cell development. (He et al., 2000; Levens et al., 1997; Michelotti et al.,
Brg-deficient cells died of apoptosis as a result of a
1996). However, FBP cannot bind FUSE unless FUSE is
defect in Bcl-2 expression, as the death was suppress-
first melted, but FUSE only melts as Myc is expressed.ible by Bcl-xL. Bcl-xL rescued cells were cell cycle ar-
That Brg directly binds the Myc promoter suggests onerested, indicating that Brg mutation impaired both the
solution to this dilemma: TCF first recruits BAF com-survival and proliferation of early thymocytes. The cell
plexes, which subsequently denature neighboring DNAcycle arrest of the DN4 cells, and presumably DN2 cells
sequences by producing torsional stress (Havas et al.,as well, was secondary, at least in part, to Myc repres-
2000). Indeed, the FUSE in the human Myc promoter ission, perhaps as a result of the disruption of the Wnt
located 451 bp upstream of a functional TCF site (He etpathway. The death/cell cycle arrest of DN2 cells addi-
al., 1998), and a putative mouse FUSE is located onlytionally resulted from the loss of Wnt-dependent c-Kit
182 bp upstream of the proximal TCF site that bindsexpression. Indeed, the selective DN2 but not DN3
Brg in vivo (D. Levens, personal communication; seedepletion in the c-Kit mutant (Figure 4D) bears striking
Supplemental Figure S5 at http://www.immunity.com/resemblance to the FACS profile in the TCF-1 null mice
(Schilham et al., 1998), suggesting that TCF-1 mutation cgi/content/full/19/2/169/DC1).
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at Stanford Animal Facility. c-Kit null mice (WBB6F1/J-KitW/KitWv)Sequential Roles of Brg in
were purchased from Jackson lab.Developmental Transitions
Bcl-xL overexpression, though able to rescue the death
Flow Cytometryof Brg-deficient cells, failed to restore T cell develop- Single-cell suspensions were prepared from 3-7 week mice and
mental progression. Thus Brg has a specific role in T cell typically stained with antibodies conjugated to APC, Texas Red,
differentiation independent of cell survival or prolifera- FITC, PE and Cy5; propidium iodide (PI) was used to eliminate dead
cells. Specifically, to analyze CD4/CD8 expression in various sub-tion. A parsimonious explanation is that the disruptions
sets of DN cells, cells were stained with anti-CD4-APC, anti-CD8-of the Wnt and pre-TCR pathways contribute to or even
Texas-Red, anti-CD25-FITC, anti-CD44-PE, anti-CD3/B220-Cy5/PI,account for the defects in the differentiation of Brg-
and the Cy5/PI/lo populations, representing live immature thymo-deficient cells. However, it has been argued that Wnt cytes, were resolved into DN1-3 and post-DN3 cells as described
and pre-TCR propel DN cell development largely by (Chi et al., 2002). To analyze c-Kit expression, cells were stained with
promoting DN cell survival and/or proliferation as op- anti-CD4-APC, anti-CD25-biotin, anti-CD44-PE, anti-CD3/8/TCR/
B220-Cy5/PI, anti-c-Kit –FITC, washed, and stained with Straptavi-posed to bona fide differentiation (Jiang et al., 1996;
din-Texas Red. IL-7R expression was determined by first stainingNewton et al., 2000; Petrie et al., 2000; Wu and Strasser,
the cells with anti-CD4-APC, anti-CD25-FITC, anti-CD44-PE, anti-2001). Therefore, additional or even distinct signals may
IL7R-biotin, anti-CD3/8/TCR/B220-Cy5/PI before incubation inuse Brg to drive DN cell differentiation. Recent observa- Straptavidin-Texas Red. To assay cell proliferation, BrdU (10ug/ul)
tions indicate that chromatin remodeling complexes can was injected intraperitoneally at 50ug/g weight and mice sacrificed
be regulated by inositol derivatives. Thus PIP2 induces 15 min later. Cell surface markers were stained with the same anti-
bodies as in the case of c-Kit analysis except that that PI andthe rapid association of the complexes with chromatin in
anti-c-Kit were omitted. Cells were then fixed, permeabilized andvitro (Zhao et al., 1998) apparently via a direct interaction
subsequently stained with anti-BrdU-FITC using BrdU-Flow Kitwith Brg (Rando et al., 2002). Similarly, inositol polyphos-
(Pharmingen) following the manufacturer’s protocol. Bcl-2 andphates directly regulate nucleosome mobilization by PCNA expression was determined as in the case of BrdU, except
multiple yeast chromatin remodeling complexes in vitro, that anti-Bcl-2-FITC and anti-PCNA-FITC, respectively, were used
and influence chromatin remodeling in vivo (Shen et al., instead of anti-BrdU-FITC.
2003; Steger et al., 2003). Thus BAF complexes might
PCR, RT-PCR and Chromatin IPact as inline signaling molecules in inositol signaling.
Primers for detecting the floxed Brg allele (Sumi-Ichinose et al.,Inositol signaling is thus a good candidate for the addi-
1997), Brg and Brm transcripts (Bultman et al., 2000) have beentional control of Brg-dependent developmental transi-
described. To measure the target genes of various signaling path-
tions. ways, we performed real-time RT-PCR on Icycler (Biorad) using
The effect of chromatin remodeling in response to Quantitect One-Step RT-PCR mix (Qiagen). Mature V transcription
transient signals is not restricted to immediate gene and VDJ recombination were measured based on published PCR
strategy (Anderson et al., 1992). ChIP was performed as describedregulation. Chromatin alteration is often initiated and
(Chi et al.,2002) except that real time PCR was used to quantifyinherited without concomitant or sustained changes in
precipitated DNA. Primer sequences and PCR conditions are avail-gene expression, but functions to pattern the chromatin
able upon request.
and poise the genes for later induction (Agarwal et al.,
1999). A classical example is that the IL-2 locus is par- Acknowledgments
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